Literature DB >> 11355474

[Prelaryngeal lymph node (Delphian) in patients with laryngeal cancer].

A Gawlak-Prycka1.   

Abstract

In the ENT Dept K. Marcinkowski University of Medical Sciences in Poznań between 1984-1998 2145 laryngectomies were performed (710 partial and 1435 total). 192 samples of macroscopically changed tissues were collected from prelaryngeal area during operations. On the basis of histological examination there were 24 cases of lymph nodes with neoplastic metastases and 132 cases lymph nodes without changes or with inflammatory changes. Relapse of tumor during two years after the operations was found in 15/24 (62.4%) in the group with positive Delphian lymph node. In the group with lymph node without changes, relapse of tumor was found in 23/132 (17.4%) patients. In the group with positive Delphian node in 8 cases, metastases were found also in lateral lymph nodes of the neck. In 75% cases (6/8) relapse of tumor was observed. The frequency of relapse was statistically higher in patients with a positive Delphian node. The presence of metastases in prelaryngeal lymph node is a significant unfavourable prognostic factor.

Entities:  

Mesh:

Year:  2001        PMID: 11355474

Source DB:  PubMed          Journal:  Otolaryngol Pol        ISSN: 0030-6657


  3 in total

1.  The impact of prelaryngeal node metastases on early glottic cancer treatment results.

Authors:  Małgorzata Wierzbicka; Małgorzata Leszczyńska; Anna Młodkowska; Witold Szyfter; Anna Bartochowska
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-07       Impact factor: 2.503

2.  Swimmer's CT: improved imaging of the lower neck and thoracic inlet.

Authors:  Arthur G Kane; Kevin C Reilly; Thomas F Murphy
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

3.  Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Won Woong Kim; Song I Yang; Jeong Hoon Kim; Young Sik Choi; Yo-Han Park; Su Kyoung Kwon
Journal:  World J Surg Oncol       Date:  2012-10-30       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.